Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI İLAÇ SANAYI VE TICARET A.Ş. Istanbul TR
01 1Amlodipine besilate
01 1France
01 1Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 2005-052 - Rev 05
Status : Valid
Issue Date : 2021-02-25
Type : Chemical
Substance Number : 1491
20
Sanofi İlaÇ Sanayi Ve Ticaret A.Ş. Istanbul Tr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Amlodipine besilate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-052 - Rev 05
This Chemical Type CEP, issued on February 25, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1491 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
